65658 Federal Register / Vol. 60, No. 244 / Wednesday, December 20, 1995 / Notices

IV. Request for Comments

The Board requests comments on all

aspects of the survey. The Board

specifically requests comments on the

following aspects:

A. Whether the proposed collection of

information is necessary for the proper

performance of the Federal Reserve’s

functions, including whether the

information has practical utility;

B. Ways to enhance the quality,

utility, and clarity of the information to

be collected;

C. The accuracy of the Federal

Reserve’s estimate of the burden of the

proposed information collection,

including the validity of the

methodology and assumptions used;

and

D. Ways to minimize the burden of

the information collection on

respondents, such as using automated

collection techniques or other forms of

information technology.

Board of Governors of the Federal Reserve

System, December 15, 1995.

William W. Wiles,

Secretary of the Board.

[FR Doc. 95–30892 Filed 12–19–95; 8:45am]

Billing Code 6210–01–P

Kenneth B. and Moira F. Mumma, et al.;

Change in Bank Control Notices;

Acquisitions of Shares of Banks or

Bank Holding Companies

The notificants listed below have

applied under the Change in Bank

Control Act (12 U.S.C. 1817(j)) and §

225.41 of the Board’s Regulation Y (12

CFR 225.41) to acquire a bank or bank

holding company. The factors that are

considered in acting on the notices are

set forth in paragraph 7 of the Act (12

U.S.C. 1817(j)(7)).

The notices are available for

immediate inspection at the Federal

Reserve Bank indicated. Once the

notices have been accepted for

processing, they will also be available

for inspection at the offices of the Board

of Governors. Interested persons may

express their views in writing to the

Reserve Bank indicated for that notice

or to the offices of the Board of

Governors. Comments must be received

not later than January 3, 1996.

A. Federal Reserve Bank of

Philadelphia (Michael E. Collins, Senior

Vice President) 100 North 6th Street,

Philadelphia, Pennsylvania 19105:

1. Kenneth B. and Moira F. Mumma

, to acquire a total of 27.5 percent of the

voting shares of New Century Bank,

Phoenixville, Pennsylvania (in

organization).

B. Federal Reserve Bank of St. Louis

(Randall C. Sumner, Vice President) 411

Locust Street, St. Louis, Missouri 63166:

1. Joseph H. Frampton, Paducah,

Kentucky; to acquire an additional 2.91

percent, for a total of 27.02 percent, of

the voting shares of Paducah Bank

Shares, Inc., Paducah, Kentucky, and

thereby indirectly acquire Paducah

Bank and Trust Company, Paducah,

Kentucky.

Board of Governors of the Federal Reserve

System, December 14, 1995.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 95–30854 Filed 12–19–95; 8:45 am]

BILLING CODE 6210–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 95F–0402]

Peroxid-Chemie GmbH; Filing of Food

Additive Petition

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that Peroxid-Chemie GmbH has filed a

petition proposing that the food additive

regulations be amended to provide for

the safe use of di(4-methylbenzoyl)

peroxide as an accelerator for silicone

polymers and elastomers for use in

contact with food.

DATES: Written comments on the

petitioner’s environmental assessment

by January 19, 1996.

ADDRESSES: Submit written comments

to the Dockets Management Branch

(HFA–305), Food and Drug

Administration, 12420 Parklawn Dr.,

rm. 1–23, Rockville, MD 20857.

FOR FURTHER INFORMATION CONTACT: Vir

D. Anand, Center for Food Safety and

Applied Nutrition (HFS–216), Food and

Drug Administration, 200 C St. SW.,

Washington, DC 20204, 202–418–3081.

SUPPLEMENTARY INFORMATION: Under the

Federal Food, Drug, and Cosmetic Act

(sec. 409(b)(5) (21 U.S.C. 348(b)(5))),

notice is given that a food additive

petition (FAP 6B4489) has been filed by

Registration and Consulting Co., Ltd., on

behalf of Peroxid-Chemie GmbH, c/o

Bruce A. Schwemmer, 55 River Dr.

South No. 1808, Jersey City, NJ 07310.

The petition proposes to amend the food

additive regulations in § 177.2600

Rubber articles intended for repeated

use (21 CFR 177.2600) to provide for the

safe use of di(4-methylbenzoyl)

peroxide as an accelerator for silicone

polymers and elastomers complying

with 21 CFR 177.2600 for use in contact

with food.

The potential environmental impact

of this action is being reviewed. To

encourage public participation

consistent with regulations promulgated

under the National Environmental

Policy Act (40 CFR 1501.4(b)), the

agency is placing the environmental

assessment submitted with the petition

that is the subject of this notice on

public display at the Dockets

Management Branch (address above) for

public review and comment. Interested

persons may, on or before January 19,

1996, submit to the Dockets

Management Branch (address above)

written comments. Two copies of any

comments are to be submitted, except

that individuals may submit one copy.

Comments are to be identified with the

docket number found in brackets in the

heading of this document. Received

comments may be seen in the office

above between 9 a.m. and 4 p.m.,

Monday through Friday. FDA will also

place on public display any

amendments to, or comments on, the

petitioner’s environmental assessment

without further announcement in the

Federal Register. If, based on its review,

the agency finds that an environmental

impact statement is not required and

this petition results in a regulation, the

notice of availability of the agency’s

finding of no significant impact and the

evidence supporting that finding will be

published with the regulation in the

Federal Register in accordance with 21

CFR 25.40(c).

Dated: December 4, 1995.

Alan M. Rulis,

Director, Office of Premarket Approval,

Center for Food Safety and Applied Nutrition.

[FR Doc. 95–30887 Filed 12–19–95; 8:45 am]

BILLING CODE 4160–01–F

[Docket No. 95N–0405]

Drug Export; SELECTOGEN 0.8%,

Reagent Red Blood Cells

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that Ortho Diagnostic Systems, Inc., has

filed an application requesting approval

for the export of the human biological

product SELECTOGEN 0.8%, Reagent

Red Blood Cells to Australia, Austria,

Belgium, Canada, Denmark, The Federal

Republic of Germany, Finland, France,